CRP and rheumatoid arthritis: A difference in baseline disease activity was apparent in 1L vs 2L subgroups when assessed using DAS28 ESR (P < 0.005) or DAS28 CRP (P < 0.05), indicating a higher RA activity in biologic treatment-naïve, 1L patients.